Brevan Howard Capital Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,460
Closed -$70.3K 2292
2025
Q4
$70.3K Sell
10,460
-13,753
-57% -$103K ﹤0.01% 1686
2025
Q3
$198K Buy
+24,213
New +$181K ﹤0.01% 1758

Other funds holding INGN

Brevan Howard Capital Management's INGN Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Inogen (INGN) in Q1 2026, closing a stake of 10,460 shares — an estimated $70.3K sold.

Brevan Howard Capital Management first reported a position in INGN in Q3 2025 and held it in 2 quarters. The position peaked at $198K in Q3 2025. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Inogen position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 10,460 Inogen shares in Q1 2026, an estimated $70.3K.
  • Brevan Howard Capital Management first reported a position in Inogen in Q3 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Inogen position peaked at $198K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.